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There are 3 kinds of blood vessel grafts for the clinical use in the current: 
autologous blood vessels,allogeneic blood vessels and vascular synthetic 
materials.Autologous blood vessels are the most suitable because of no immune 
response,while limited by quantity,sources,and  the possibility of damaging to the 
patients;Allogeneic blood vessels are prone to immune rejection;Polymer synthetic 
blood vessels are restricted to diameter to the preparation of small blood vessels.The 
Stent synthetic polymer materials has been successfully applied in the large diameter 
of blood vessels,but the small blood vessels (diameter 6 mm or less) has not been 
applied successfully so far.So the construction of small diameter artificial blood 
vessels,the application of the principle of biology and engineering to build a new type 
of tissue engineering artificial blood vessels is very important. 
Extracellular matrix (ECM) that composed of large molecules such as 
collagen,the collagen glycoprotein and glycosaminoglycans sugar complex is a 
biological networks structure.Extracellular matrix is a special kind of natural 
biological derivatives,providing physical support for cell growth and suitable living 
environment, and regulating the cell adhesion,growth,proliferation and differentiation 
through the signal transduction,ECM plays an important regulatory role in the growth 
process of cell differentiation and tissue trauma repairation and regeneration.Natural 
extracellular matrix has the advantages of synthetic scaffold materials and overcomes 
its shortcomings,and has low immunogenicity and excellent biological characteristics. 
Hepatic fibrosis is a wound-healing response that engages a range of cell types 
and mediators to encapsulate injury.Hepatic fibrosis is characterized by an abnormal 
deposit of extracellular matrix (ECM) constituents,especially typeⅠcollagen.The 
activated hepatic stellate cell (HSC) is responsible for increased collagen synthesis 
during liver fibrosis.TypeⅠcollagen comes mainly from the activation of hepatic 
stellate cells.Studies have demonstrated that the damage of hepar can promote the 















Ⅰ.These cells are activated by fibrogenic cytokines such as TGF-β1,angiotensin II. 
Liver fibrosis is the excessive accumulation of extracellular matrix proteins 
including collagenthat occurs in most types of chronic liver diseases.Advanced liver 
fibrosis results in cirrhosis,liver failure,and portal hypertension and often requires 
liver transplantation.Our knowledge of the cellular and molecular mechanisms of liver 
fibrosis has greatly advanced.Activated hepatic stellate cells,portal fibroblasts,and 
myofibroblasts of bone marrow origin have been identified as major 
collagen-producing cells in the injured liver.  
TGF-β1 can activate the hepatic stellate cells (HSCs) to enhance the secretion of 
extracellular matrix (ECM) which plays a key role for the development of liver 
fibrosis.So in this research,we will employ the ability of activated HSCs to prepare 
human-derived ECM biological vascular grafts.According to our previous study,the 
activated HSCs presented a stronger ability in secretion of collagen than fibroblasts, 
we will prepare PCL-gelatin nanofibers vascular scaffold with electrospinning.We 
will seed activated HSCs on the PCL-gelatin scaffold. The activated HSCs will 
secrete ECM such as collagen on the prepared vascular scaffold which will be 
cultured under self-made vascular bio-reactor.The ECM nanofibers are remodeled 
under the stress,and crosslink with PCL nanofibers.At intervals,the ECM will be 
analyzed for an ideal production parameter.The HSCs-ECM-PCL vascular 
construction will be decellularized and lyophilized,and modified with heparin 
chitosan hydrogel for anticoagulant ability.The anticoagulant ECM-PCL vascular 
graft will be implanted for arteriovenous hemodialysis access in animal model.The 
analysis of the original ECM and PCL degradation, host immune and vascular cells 
infiltration, different layers of vascular wall formation or regeneration and host ECM 
regeneration will be carried out to confirm vascular mature duration and characters. 
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第一章  绪论 













































1.2  组织工程血管的构建 
目前对于组织工程血管的构建主要包含了 3 个非常重要的部分 9。 
首先是种子细胞的选择：选择适合重建组织工程血管（TEBVs）并且能够大
量产生细胞自体纤维即细胞外基质(ECM)的细胞，然后使其增殖和分化；目前发

















































































1.2.2.1  3D 生物打印材料 




能将 3D 生物打印血管用于临床 21, 22。 
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